Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127214231 | 12721423 | 1 | I | 201608 | 0 | 20160906 | 20160906 | DIR | FDA-CTU | 57.00 | YR | F | N | 0.00000 | 20160902 | N | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127214231 | 12721423 | 1 | PS | TYKERB | LAPATINIB DITOSYLATE | 1 | Oral | D | D | 0 | 4 | DF | COATED TABLET | QD | |||||
127214231 | 12721423 | 2 | SS | CAPECITABINE 500MG TEVA | CAPECITABINE | 1 | Oral | D | D | 3A508049 | 20170831 | 0 | 2 | DF | COATED TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127214231 | 12721423 | 1 | Breast cancer |
127214231 | 12721423 | 2 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127214231 | 12721423 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127214231 | 12721423 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
127214231 | 12721423 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127214231 | 12721423 | 1 | 20160505 | 201608 | 0 | |
127214231 | 12721423 | 2 | 20160505 | 201608 | 0 |